News
OTCA18 Final Project Plan – Regional hyperthermia for high-risk soft tissue sarcoma treatment – now available
The Final OTCA18 Project Plan on ‘Regional hyperthermia for high-risk soft tissue sarcoma treatment’ is now available for access, together with comments from external experts,
REQueST tool and its Vision paper Public Consultation – Now closed
The Haute Autorité de Santé (HAS), National Institute for Health and Care Excellence (NICE) & the Croatian Institute for Public Health (HZJZ) are pleased
OTCA11 Final Assessment – Now Available
We are pleased to announce that the collaborative rapid assessment, OTCA11, on “Custom-made or customisable 3D printed implants and cutting guides versus non-3D printed standard
EUnetHTA 2019 Assembly & Forum Welcome Guide – Now Available
To accompany the upcoming EUnetHTA 2019 Assembly & Forum 0n 10-11th April in Amsterdam, a Welcome Guide has been developed to give participants and
Declaration of Interest and Confidentiality Agreement (DOI) – Documents Now Available
EUnetHTA has developed documentation to address Conflict of Interest (COI) concerns and assist in the decision-making process relating to the assessment of individuals potentially involved
Open Call for Patient Input – Joint Assessment on a medicinal product for secondary progressive MS.
EUnetHTA recently started a new Joint Assessment on a medicinal product for secondary progressive MS. To find out about participation, please read more here. Input submissions
2019 EUnetHTA Forum Agenda – Now Available
The day’s agenda is now available for the upcoming 2019 EUnetHTA Forum on 11th April at the West-Indisch Huis in central Amsterdam. We are looking
EUnetHTA Magazine: Winter 2019
Assessment Publication: Jointly Produced HTA Report; Partner Profile: Austria; Impact: Austria; Partner Profile: UK; Innovation & HTA: Giovanni Tafuri; Prioritisation List: Topics & Joint Assessments;
PTJA04 – “Sotagliflozin is indicated as an adjunct to insulin therapy to improve glycaemic control in adults with type 1 diabetes mellitus with a Body Mass Index (BMI) ≥ 27 kg/m2, who have failed to achieve adequate glycaemic control despite optimal insulin therapy” is now available
This is the assessment of the relative effectiveness of ‘Sotagliflozin is indicated as an adjunct to insulin therapy to improve glycaemic control in adults with
EUnetHTA 2019 Forum
Registration has now closed for the EUnetHTA 2019 Forum, held this year at the West-Indisch Huis in Amsterdam, the Netherlands, on 11 April 2019. Consisting
